Key facts
- This page summarizes John Nosenzo's Form 4 filing for TELA Bio, Inc. (TELA).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 02 Jun 2023, 16:36.
John Nosenzo - 01 Jun 2023 Form 4 Insider Report for TELA Bio, Inc. (TELA)
- Reporting relationship
- Director
- Issuer ticker
- TELA
- Reported as of
- 01 Jun 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 02 Jun 2023, 16:36:54 UTC
- Prior SEC filing
- 02 Jun 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Megan Smeykal, Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
John Nosenzo filed Form 4 for TELA Bio, Inc. (TELA) on 02 Jun 2023.
Change
- Previous filing in this sequence was filed on 02 Jun 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TELA
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +3,135
- Change %
- +100%
- Price
- $0.000000
- Shares after
- 6,270
- Date
- 01 Jun 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TELA
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +5,360
- Change %
- Price
- $0.000000
- Shares after
- 5,360
- Date
- 01 Jun 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,360
- Exercise price
- $10.34
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
These restricted stock units vest on the earlier of (a) June 1, 2024, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.
Footnote F2
The option vests on the earlier of (a) June 1, 2024, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.